Why Oura chose Wall Street over Helsinki for its $16B IPO and what its early backers think

Earlier this month, Oura, the Finnish healthtech decacorn, submitted an application to list on Nasdaq, aiming to raise up to $3 billion at a valuation exceeding $16 billion. This represents a 45% increase over the $11 billion valuation it achieved in...